Profile of the Anti-inflammatory Mediator Interleukin-10 (IL-10) in Patients Suspected of Covid-19
DOI:
10.29303/jbt.v24i4.7658Published:
2024-10-15Downloads
Abstract
Severe acute respiratory syndrome corona virus 2 (SARSCOV-2) is a virus that causes corona virus desease (Covid-19), namely a respiratory sindrome desease that comes from the beta corona virus group. A serious problem with Sarscov-2 infection is when a cytokine storm appears which is produced as the body’s response to an inflammatory reaction, but the presence of interleukin (cytokine)-10 as an anti-inflammatory cytokine can suppress inflammatory reactions to avoid cytokine storms. The study's objective was to characterize IL-10 levels in people who may have Covid-19. The research method is to use an analytical survey with a retrospective design. Interleukin-10 levels were measured utilizing the ELISA (Enzime Linked Immunosorbant Assay) method. Result: The average level of IL-10 in SARSCOV-2 utilizing the Real Time Polymerase Chain Reaction (RT-PCR) method to detect positive Covid-19 suspect samples (83.16 pg/ml) was higher than SARSCOV-2 negative Covid-19 suspects (81.03 pg/ml). Conclusion: the comparison of IL-10 levels in positive Covid-19 suspects and negative Covid-19 suspects using the RT-PCR technique has an insignificant difference in levels because naturally Pro- and anti-inflammatory cytokines' reciprocal responses show that the immune response of the samples from suspected Covid-19 patients used is still very strong (IL-10).
Keywords:
Anti-inflammatory mediator, cytokin IL-10, suspected Covid-19.References
Bosch, B. J., van der Zee, R., de Haan, C. A., & Rottier, P. J. (2003). The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex. Journal of Virology, 77(16), 8801–8811 https://doi.org/10.1128/jvi.77.16.8801-8811.2003.
Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology, 39(5), 529–539 https://doi.org/10.1007/s00281-017-0629-x.
Chen, L. D., Wei, X. J., Cai, Y. Q., Yao, W. Z., Wang, M. H., Huang, Q. F., & Zhang, X. B. (2020). Association between cytokine profiles and lung injury in COVID-19 pneumonia . Respiratory Research, 21(1), 1–8. https://doi.org/10.1186/s12931-020-01465-2.
Covid-19 Hotline. (2020). Retrieved from https://covid19.go.id/
Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Biomedica, 91(1), 157–160 https://doi.org/10.23750/abm.v91i1.9397.
Dhar, S., V, K., Damodar, S., Gujar, S., & Das, M. (2021). IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon, 7(2), 1-5. doi:https://10.1016/j.heliyon.2021.e06155
Dodoo, D., Omer, F. M., Todd, J., Akanmori, B. D., Koram, K. A., & Riley, E. M. (2002). Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. Journal of Infectious Diseases, 185(7), 971–979 . doi:https://doi.org/10.1086/339408
Fadhilah, N., Soegiarto, G., Budhy, T., & Kes, M. (2021). Potential of IL-10 as Targeted Therapy in Severe COVID-19 Patients. Malaysian Journal of Medicine and Health Sciences, 17, 165-168. Retrieved from https://scholar.unair.ac.id/en/publications/potential-of-il-10-as-targeted-therapy-in-severe-covid-19-patient
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020). COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Int. J. Mol. Sci, 21(10), 1–23. doi:https://10.3390/ijms21103474
He, S., Zhou, C., Lu, D., Yang, H., Xu, H., Wu, G., . . . Wu, X. (2020). Relationship between chest CT manifestations and immune response in COVID-19 patients. International Journal of Infectious Diseases, 98, 125–129. doi:https://doi.org/10.1016/j.ijid.2020.06.059
Mau, F., & Tallan, M. M. (2016). Gambaran Peningkatan Kadar Inter Leukin-10 (IL-10) dan Tumor Necrosis Faktor – Alfa (TNF-α) dengan Gejala Klinis pada Penderita Malaria. Buletin Penelitian Kesehatan , 44(3), 181–186 . doi:https://doi.org/10.22435/bpk.v44i3.4806.
Mouna, B. A., Awatef Ben, J., Walid, S., Chihebeddine, R., Ridha, O., Hedi, G., . . . Mustapha, F. (2022). Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients. Immunobiology, 227(4), 1-12. doi:https://doi.org/10.1016/j.imbio.2022.152236
Rosyanti, L., & Hadi, I. (2020). The Immunity Response and Severe Acute Respiratory Syndrome Coronavirus-2 Cytokine Storm Literature Review. Jurnal Kesehatan Madani Medika, 11(2), 176–201. Retrieved from www.jurnalmadanimedika.ac.id
Sama, I. E., Ravera, A., Santema, B. T., Goor, H. v., Maaten, J. M., Cleland, J. G., . . . Filippatos, G. (2020). Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J, 41(19), 1810-1817. doi:https://10.1093/eurheartj/ehaa373
Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., . . . & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798) , 265–269 https://doi.org/10.1038/s41586-020-2008-3.
Zeng, Z., Yu, H., Chen, H., Qi, W., Chen, L., Chen, G., . . . Wu, D. (2020). Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. Critical Care, 24(1) , 1–12 https://doi.org/10.1186/s13054-020-03255-0.
License
Copyright (c) 2024 Edy Kurniawan, Pauzan Pauzan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
